Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Hotchkis & Wiley Large Cap Fundamental Value. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+33.7%
YTD+5.28%
Annualized+0.0836%
Positioning StanceCONSTRUCTIVE
Market CapLarge Cap
Digest Analysis
Quick Take
"Tech-led quarter. The managers utilized short-term healthcare volatility to buy UnitedHealth Group and remain confident that active value will benefit from wide valuation spreads."
Executive Summary
In Q2 2025, the Hotchkis & Wiley Large Cap Disciplined Value Fund returned 3.37%, performing in line with the Russell 1000 Value Index (3.79%). The quarter was defined by extreme volatility—driven by initial tariff announcements followed by the fastest-ever market recovery from a -15% drawdown—and sharp style divergence, with growth significantly outperforming value. Stock selection in financials, healthcare, and an overweight in technology aided relative performance, while industrials and energy detracted. The fund capitalized on market panic in the healthcare sector to buy UnitedHealth Group at an attractive price. The managers remain constructive on their disciplined value holdings, highlighting F5 Inc. as their largest position and expressing long-term optimism regarding active value strategies.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
80%
CautiousHigh
High Conviction (80%)
High-conviction positioning: The fund delivered 3.37% in a highly concentrated, tech-led quarter. The managers utilized short-term healthcare volatility to buy UnitedHealth Group and remain confident that acti...
Growth Outlook
60%
BearishBullish
Neutral (60%)
Market outlook remains above average conviction: The fund delivered 3.37% in a highly concentrated, tech-led quarter. The managers utilized short-term healthcare volatility to buy UnitedHealth Group and remain confident that acti...
Risk Appetite
60%
DefensiveAggressive
Balanced (60%)
Risk appetite posture is above average conviction: The fund delivered 3.37% in a highly concentrated, tech-led quarter. The managers utilized short-term healthcare volatility to buy UnitedHealth Group and remain confident that acti...
Capital Deployment
70%
De-riskingDeploying
Deploying (70%)
Manager actively deployed capital into high-conviction opportunities. The fund delivered 3.37% in a highly concentrated, tech-led quarter. The managers utilized short-term healthcare volatility to buy UnitedHealth Group and remain confident that acti...
Forward Guidance
50%
CautiousExpansionary
Neutral (50%)
Forward guidance signal: The fund delivered 3.37% in a highly concentrated, tech-led quarter. The managers utilized short-term healthcare volatility to buy UnitedHealth Group and remain confident that acti...
Language Signal
70%
BearishBullish
Bullish (70%)
Tone analysis indicates above average conviction language: The fund delivered 3.37% in a highly concentrated, tech-led quarter. The managers utilized short-term healthcare volatility to buy UnitedHealth Group and remain confident that acti...
Perceived Risk
40%
Low RiskElevated
Moderate Risk (40%)
Perceived risk level is evaluated as moderate conviction. The fund delivered 3.37% in a highly concentrated, tech-led quarter. The managers utilized short-term healthcare volatility to buy UnitedHealth Group and remain confident that acti...
Opportunity Density
70%
ScarceAbundant
Abundant (70%)
Opportunity density index indicates above average conviction actionable entry points. The fund delivered 3.37% in a highly concentrated, tech-led quarter. The managers utilized short-term healthcare volatility to buy UnitedHealth Group and remain confident that acti...
Time Horizon
80%
Short-TermLong-Term
Decade+ (80%)
Investment time horizon reflects a high conviction orientation. The fund delivered 3.37% in a highly concentrated, tech-led quarter. The managers utilized short-term healthcare volatility to buy UnitedHealth Group and remain confident that acti...